339 results on '"Yang, David T."'
Search Results
2. A gain-of-function p53 mutant synergizes with oncogenic NRAS to promote acute myeloid leukemia in mice
3. MerTK Drives Proliferation and Metastatic Potential in Triple-Negative Breast Cancer
4. Autoimmune Lymphoproliferative Syndrome
5. Chronic Myeloid Leukemia, Version 2.2024, NCCN Clinical Practice Guidelines in Oncology
6. Recent Advances in Imaging Macular Atrophy for Late-Stage Age-Related Macular Degeneration
7. Autoimmune Lymphoproliferative Syndrome: An Overview
8. PRMT5 is upregulated by B-cell receptor signaling and forms a positive-feedback loop with PI3K/AKT in lymphoma cells
9. Induced Pluripotent Stem Cell Model of Chronic Myeloid Leukemia Revealed Olfactomedin 4 As a Novel Survival Factor for Primitive Leukemia Cells
10. Multicenter Analysis of Advanced Stage Grade 3A Follicular Lymphoma Outcomes by Frontline Treatment Regimen
11. VcR-CVAD Induction Chemotherapy Followed by Maintenance Rituximab Produces Durable Remissions in Mantle Cell Lymphoma: A Wisconsin Oncology Network Study
12. Data from EGR1 Addiction in Diffuse Large B-cell Lymphoma
13. Supplementary Table 1 from EGR1 Addiction in Diffuse Large B-cell Lymphoma
14. Supplementary Methods, Supplementary Figures 1-10 from EGR1 Addiction in Diffuse Large B-cell Lymphoma
15. Supplementary Table 2 from Development and Characterization of HPV-Positive and HPV-Negative Head and Neck Squamous Cell Carcinoma Tumorgrafts
16. Data from Development and Characterization of HPV-Positive and HPV-Negative Head and Neck Squamous Cell Carcinoma Tumorgrafts
17. Supplementary Table 1 from Development and Characterization of HPV-Positive and HPV-Negative Head and Neck Squamous Cell Carcinoma Tumorgrafts
18. Supplementary Figure 1 from Development and Characterization of HPV-Positive and HPV-Negative Head and Neck Squamous Cell Carcinoma Tumorgrafts
19. Follicular lymphoma: evolving therapeutic strategies
20. Urrets-Zavalia Syndrome of Unresolving Mydriasis Following Endocyclophotocoagulation Combined with Phacoemulsification.
21. Phase 1 Trial of Bevacizumab With Concurrent Chemoradiation Therapy for Squamous Cell Carcinoma of the Head and Neck With Exploratory Functional Imaging of Tumor Hypoxia, Proliferation, and Perfusion
22. Randomized Phase 2 Trial of First-Line Bendamustine-Rituximab (BR)-Based Induction Followed By Rituximab (R) ± Lenalidomide (L) Consolidation for Mantle Cell Lymphoma ECOG-ACRIN E1411
23. Clonality and mutational profiling of a case of composite hairy cell leukemia and chronic lymphocytic leukemia
24. Defective Antigen Tubes Generate False-Positive QuantiFERON Tuberculosis Test Results
25. Phase 2 study of VcR-CVAD with maintenance rituximab for untreated mantle cell lymphoma: an Eastern Cooperative Oncology Group study (E1405)
26. NR4A1 inhibition synergizes with ibrutinib in killing mantle cell lymphoma cells
27. Abstract 1334: MerTK tumorigenesis and immune evasion mechanisms in triple negative breast cancer
28. Microscale functional cytomics for studying hematologic cancers
29. Impact of oncogene rearrangement patterns on outcomes in patients with double-hit non-Hodgkin lymphoma
30. Genomewide DNA methylation analysis reveals novel targets for drug development in mantle cell lymphoma
31. Efficient assessment of peripheral blood lymphocytosis in adults: developing new thresholds for blood smear review by pathologists
32. ECOG-ACRIN E1411 randomized phase 2 trial of bendamustine-rituximab (BR)-based induction followed by rituximab (R) ± lenalidomide (L) consolidation for Mantle cell lymphoma: Effect of adding bortezomib to front-line BR induction on PFS.
33. EGR1 Addiction in Diffuse Large B-cell Lymphoma
34. Intrinsic Factor Blocking Antibody Interference Is Not Detected in Five Automated Cobalamin Immunoassays
35. Immunohistochemical evaluation of MYC expression in mantle cell lymphoma
36. Anti-inflammatory effects of PPAR-γ agonists directly correlate with PPAR-γ expression during acute pancreatitis
37. Diagnostic challenges in an aggressive case of peripheralizing marginal zone lymphoma
38. Chronic Myeloid Leukemia, Version 2.2021, NCCN Clinical Practice Guidelines in Oncology
39. Laboratory testing for cobalamin deficiency in megaloblastic anemia
40. Spurious Elevations of Vitamin B12 with Pernicious Anemia
41. VcR-CVAD induction chemotherapy followed by maintenance rituximab in mantle cell lymphoma: a Wisconsin Oncology Network study
42. Nuclear Export of the NF-κB Inhibitor IκBα Is Required for Proper B Cell and Secondary Lymphoid Tissue Formation
43. Metabolic Rewiring in Response to Biguanides Is Mediated by mROS/HIF-1a in Malignant Lymphocytes
44. Proapoptotic protein BIM as a novel prognostic marker in mantle cell lymphoma
45. Nodular lymphocyte predominant Hodgkin lymphoma at atypical locations may be associated with increased numbers of large cells and a diffuse histologic component
46. Laboratory-Developed Tests: A Critical Bridge During the COVID-19 Pandemic.
47. CD117, CK20, TTF-1, and DNA topoisomerase II-α antigen expression in small cell tumors
48. Autoimmune Lymphoproliferative Syndrome: An Overview
49. Prevalence of bortezomib-resistant constitutive NF-kappaB activity in mantle cell lymphoma
50. Randomized induction with bendamustine-rituximab plus bortezomib and maintenance with rituximab plus lenalidomide for MCL
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.